TSG Advice Partners LLC purchased a new stake in shares of iShares U.S. Healthcare ETF (NYSEARCA:IYH – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 6,472 shares of the company’s stock, valued at approximately $434,000.
Several other institutional investors and hedge funds have also bought and sold shares of IYH. Compass Financial Management LLC bought a new stake in shares of iShares U.S. Healthcare ETF during the 2nd quarter valued at about $744,000. Gerald Baker Financial Group LLC purchased a new position in shares of iShares U.S. Healthcare ETF during the first quarter valued at about $3,539,000. The Manufacturers Life Insurance Company purchased a new position in shares of iShares U.S. Healthcare ETF during the second quarter valued at about $3,297,000. McIlrath & Eck LLC purchased a new position in shares of iShares U.S. Healthcare ETF during the first quarter valued at about $490,000. Finally, Readystate Asset Management LP bought a new position in iShares U.S. Healthcare ETF in the second quarter worth about $543,000.
iShares U.S. Healthcare ETF Price Performance
IYH stock opened at $77.60 on Tuesday. iShares U.S. Healthcare ETF has a 1 year low of $59.63 and a 1 year high of $79.06. The firm has a 50-day moving average of $72.80 and a 200 day moving average of $66.87. The company has a market cap of $4.63 billion, a P/E ratio of 21.05 and a beta of 0.56.
iShares U.S. Healthcare ETF Company Profile
iShares U.S. Healthcare ETF (the Fund), formerly iShares Dow Jones U.S. Healthcare Sector Index Fund (the Fund) is a non-diversified exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the Index). The Index measures the performance of the healthcare sector of the United States equity market, and includes companies in the industry groups, such as healthcare equipment and services, pharmaceuticals and biotechnology.
Featured Articles
- Five stocks we like better than iShares U.S. Healthcare ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Want to see what other hedge funds are holding IYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Healthcare ETF (NYSEARCA:IYH – Free Report).
Receive News & Ratings for iShares U.S. Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
